Trulieve Cannabis (NYSE:TRLV) Stock Rating Lowered by Wall Street Zen

Trulieve Cannabis (NYSE:TRLV) was downgraded by stock analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a report released on Sunday.

A number of other analysts have also recently issued reports on the company. Zacks Research raised Trulieve Cannabis to a “hold” rating in a research report on Thursday, June 18th. Weiss Ratings started coverage on Trulieve Cannabis in a research note on Tuesday, June 16th. They set a “sell (d-)” rating for the company. One equities research analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, Trulieve Cannabis has an average rating of “Reduce”.

Trulieve Cannabis Stock Performance

Shares of Trulieve Cannabis stock traded down $0.26 on Friday, hitting $8.58. 1,412,550 shares of the company traded hands, compared to its average volume of 626,211. Trulieve Cannabis has a 12-month low of $4.00 and a 12-month high of $13.28.

Insider Buying and Selling at Trulieve Cannabis

In related news, CEO Kim A. Rivers sold 400,000 shares of the firm’s stock in a transaction that occurred on Wednesday, June 24th. The stock was sold at an average price of $8.17, for a total value of $3,268,000.00. Following the transaction, the chief executive officer directly owned 1,913,724 shares of the company’s stock, valued at approximately $15,635,125.08. This trade represents a 17.29% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders sold 1,699,007 shares of company stock valued at $14,661,355. 3.79% of the stock is currently owned by company insiders.

About Trulieve Cannabis

Trulieve Cannabis Corp. is a vertically integrated cannabis company focused on the cultivation, processing, and retail sale of medical and adult-use cannabis products. The company offers a range of products that may include flower, pre-rolls, concentrates, edibles, vape products, and topicals through its dispensary network and branded product portfolio.

Trulieve’s operations have been centered primarily in the United States, with a strong presence in Florida and additional markets in other states where cannabis is legally regulated.